Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Multiple Indications Cancer”

32 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 32 results

Not applicableLooking for participantsNCT06635954
What this trial is testing

A Prospective Real World Evidence Study (PROWES) for Concordance Rate of Blood-based 3D Genome Conformation Mapping (Episwitch CiRT®) to Identify Likelihood of Response and Actual Response Rates to PD-(L)-1 Checkpoint Inhibitors Across Multiple Oncological Indications.

Who this might be right for
CancerImmunotherapyPD-1+2 more
Oxford Biodynamics Inc. 2,000
Large-scale testing (Phase 3)Looking for participantsNCT04513639
What this trial is testing

The Relapse from MRD Negativity As Indication for Treatment (REMNANT) Study

Who this might be right for
Multiple Myeloma
Oslo University Hospital 176
Testing effectiveness (Phase 2)Study completedNCT05597839
What this trial is testing

Study of DF9001 in Patients With Advanced Solid Tumors

Who this might be right for
Solid Tumor, Adult
Dragonfly Therapeutics 24
Not applicableWithdrawnNCT03983486
What this trial is testing

Rationale for Cytogenetic Risk Stratification by Imaging Flow Cytometry in Multiple Myeloma

Who this might be right for
Multiple Myeloma
Centre Hospitalier Universitaire, Amiens
Testing effectiveness (Phase 2)Ended earlyNCT02465528
What this trial is testing

Ceritinib Rare Indications Study in ALK+ Tumors

Who this might be right for
Tumors With Aberrations in ALKAnaplastic Large Cell LymphomaInflammatory Myofibroblastic Tumor+1 more
Novartis Pharmaceuticals 22
Testing effectiveness (Phase 2)WithdrawnNCT01479582
What this trial is testing

Providing Access to Cord Blood Units for Transplants

Who this might be right for
Chronic Myelogous Leukemia/Other LeukemiaAcute LeukemiasMDS/MPS+2 more
National Cancer Institute (NCI)
Post-approval studies (Phase 4)Not Yet RecruitingNCT07801027
What this trial is testing

A Trial of Pembrolizumab With Chemotherapy or Chemoradiotherapy in Participants From India With Different Types of Cancer (MK-3475-G44/KEYNOTE-G44)

Who this might be right for
Neoplasm MalignantGastric NeoplasmsGastroesophageal Junction Adenocarcinoma+2 more
Merck Sharp & Dohme LLC 150
Large-scale testing (Phase 3)Looking for participantsNCT05768178
What this trial is testing

DETERMINE Trial Treatment Arm 05: Vemurafenib in Combination With Cobimetinib in Adult Patients With BRAF Positive Cancers.

Who this might be right for
Haematological MalignancyMelanomaThyroid Cancer, Papillary+9 more
Cancer Research UK 30
Early research (Phase 1)Study completedNCT03523390
What this trial is testing

Phase I/Ib Multiple Ascending Dose Study in China

Who this might be right for
Metastatic Solid Tumors
Merck KGaA, Darmstadt, Germany 24
Testing effectiveness (Phase 2)UnknownNCT03018405
What this trial is testing

A Dose Escalation Phase I Study to Assess the Safety and Clinical Activity of Multiple Cancer Indications

Who this might be right for
Acute Myeloid Leukemia/Myelodysplastic SyndromeMultiple Myeloma (MM)
Celyad Oncology SA 146
Testing effectiveness (Phase 2)Study completedNCT02297139
What this trial is testing

Continuing Treatment for Subjects Who Have Participated on a Prior Protocol Investigating Dasatinib

Who this might be right for
Multiple Indications Cancer
Bristol-Myers Squibb 17
Not applicableUnknownNCT02577627
What this trial is testing

Multi-Indication, Retrospective Oncological Study to Validate the Accuracy in Predicting TTP by PrediCare in Patients Under SOC

Who this might be right for
Non-Small Cell Lung CancerSmall Cell Lung CancerProstate Cancer+2 more
Optimata Ltd. 5,000
Testing effectiveness (Phase 2)Study completedNCT04391062
What this trial is testing

Dose Finding for Intraoperative Photodynamic Therapy of Glioblastoma

Who this might be right for
Glioblastoma
University Hospital, Lille 14
Testing effectiveness (Phase 2)Study completedNCT02649790
What this trial is testing

Study of the Safety, Tolerability and Efficacy of KPT-8602 in Participants With Relapsed/Refractory Cancer Indications

Who this might be right for
Relapsed/Refractory Multiple Myeloma (RRMM)Metastatic Colorectal Cancer (mCRC)Metastatic Castration-Resistant Prostate Cancer (mCRPC)+3 more
Karyopharm Therapeutics Inc 277
Testing effectiveness (Phase 2)Study completedNCT04143711
What this trial is testing

Study of DF1001 in Patients With Advanced Solid Tumors

Who this might be right for
Solid Tumor, Adult
Dragonfly Therapeutics 270
Large-scale testing (Phase 3)Looking for participantsNCT03829553
What this trial is testing

Hypofractionated Irradiation At Regional Nodal Area for Breast Cancer Vs Existed Standard Treatment

Who this might be right for
Breast Cancer
Ruijin Hospital 801
Testing effectiveness (Phase 2)Looking for participantsNCT04817956
What this trial is testing

Improving Public Cancer Care by Implementing Precision Medicine in Norway

Who this might be right for
Cancer Metastatic
Oslo University Hospital 3,000
Early research (Phase 1)Study completedNCT04423029
What this trial is testing

DF6002 Alone and in Combination With Nivolumab

Who this might be right for
Solid Tumors
Dragonfly Therapeutics 170
Not applicableStudy completedNCT01294722
What this trial is testing

Determine the Number of Participants With Rheumatoid Arthritis (RA) Who Meet the Requirements for Treatment With Anti-Tumor Necrosis Factor α (TNFα) in a General Hospital Setting in Korea

Who this might be right for
Rheumatoid Arthritis
Janssen Korea, Ltd., Korea 1,700
Large-scale testing (Phase 3)Looking for participantsNCT07440290
What this trial is testing

DETERMINE Trial Treatment Arm 07: Dabrafenib in Combination With Trametinib in Adult, Paediatric and Teenage/Young Adult Patients With BRAF V600 Mutation-Positive Cancers.

Who this might be right for
Haematological MalignancyMalignant NeoplasmLymphoproliferative Disorders+17 more
Cancer Research UK 30
Next Page